Streetbeat News

ZIVO

Zivo Bioscience Inc

https://zivobioscience.com/

CEO

Andrew Dahl

Employees

Industry

Biological Product (except Diagnostic) Manufacturing

zivo bioscience, inc., a u.s.-based r&d firm, is dedicated to the study, development and commercialization of natural nutritional compounds and bioactive molecules derived from proprietary algal strains.

Open

17.80

Mkt cap

67M

Volume

901

High

17.80

P/E Ratio

-4.21

52-wk high

22.15

Low

17.80

Div yield

N/A

52-wk low

3.13

Several stocks experienced significant movement in Thursday's mid-day session. Orchard Therapeutics plc (ORTX) shares climbed 97.7% after agreeing to be acquired by Japan's Kyowa Kirin. SP Plus Corporation (SP) shares gained 47.5% after Metropolis Technologies announced it will acquire the company. Accolade Inc (ACCD) shares fell 9.9% after the company reported second-quarter results. Grupo Aeroportuario del Centro Norte (OMAB) shares dipped 39.6%.

Portfolio Pulse from Lisa Levin

October 05, 2023 | 5:23 pm

Zivo Bioscience has announced the results of a month-long coccidiosis trial in broiler chickens. The company stated that all test groups demonstrated a statistically significant benefit in broiler health under simulated commercial conditions.

Portfolio Pulse from Benzinga Newsdesk

September 19, 2023 | 8:17 pm

Zivo Bioscience, Inc. (NASDAQ:ZIVO) announced that ZWorldwide, an independent distributor with exclusive rights to the Zivolife product in North America, will purchase the entire supply of Zivolife produced for the first 18 months. ZWorldwide has also committed to purchasing at least 24,000 kilograms of product for each of the next five years. ZIVO is working with Alimenta Algae to increase production volumes and expects to have significantly expanded production capacity fully operational in 2025.

Portfolio Pulse from Happy Mohamed

August 16, 2023 | 12:34 pm

Zivo Bioscience has filed a prospectus for 2,996,260 shares of common stock underlying Series A and Series B common warrants by a selling stockholder. The filing was made with the SEC.

Portfolio Pulse from Charles Gross

July 28, 2023 | 10:08 am

ZIVO Bioscience, Inc. has started selling its proprietary algal biomass as human food. This move marks the company's entry into the human food market.

Portfolio Pulse from Bill Haddad

July 26, 2023 | 8:44 pm

The article lists five oversold stocks in the consumer staples sector that could be potential investment opportunities. These include The Estée Lauder Companies Inc. (EL), Smart for Life, Inc. (SMFL), ZIVO Bioscience, Inc. (ZIVO), BRC Inc. (BRCC), and AppHarvest, Inc. (APPH). The stocks are considered oversold as their Relative Strength Index (RSI) is near or below 30. The companies have experienced various events such as price target downgrades, compliance with Nasdaq listing requirements, direct offerings, better-than-expected sales, and Chapter 11 filings.

Portfolio Pulse from Lisa Levin

July 25, 2023 | 11:29 am

On Monday, 70 companies hit new 52-week lows. Estee Lauder Cos was the largest firm by market cap to set a new 52-week low, while 9 Meters Biopharma was the smallest. AppHarvest was the biggest loser, trading down 70.3% to reach its 52-week low, while SWK Holdings was the biggest winner, with shares trading up 0.0% after rebounding from its new 52-week low.

Portfolio Pulse from Benzinga Insights

July 24, 2023 | 7:48 pm

On Monday, 50 companies reached new 52-week lows. The biggest company by market cap to set a new 52-week low was Verizon Communications (NYSE:VZ), while the smallest was Galmed Pharmaceuticals (NASDAQ:GLMD). Novan (NASDAQ:NOVN) was the biggest loser of the morning session, dropping 72.16% to reach its new 52-week low. Cal-Maine Foods (NASDAQ:CALM) shares were the most resilient, rising 0.06% from its new 52-week low.

Portfolio Pulse from Benzinga Insights

July 17, 2023 | 4:17 pm

ZIVO Bioscience has announced the pricing of a $4 million registered direct offering. The company plans to use the proceeds for general corporate purposes.

Portfolio Pulse from Benzinga Newsdesk

June 30, 2023 | 5:59 pm

Several stocks experienced significant movement in Thursday's mid-day session. Sigilon Therapeutics (SGTX) shares climbed 523.8% after Eli Lilly agreed to acquire the company. Eco Wave Power Global (WAVE) gained 47.4% after announcing plans for a share repurchase program. Franklin Covey Co. (FC) gained 25.2% following upbeat Q3 results. Carriage Services (CSV) surged 24.4% after its Board initiated a process to explore potential strategic alternatives. The Greenbrier Companies (GBX) gained 23.2% after reporting better-than-expected Q3 results and raising FY23 revenue guidance. On the downside, BioXcel Therapeutics (BTAI) shares dipped 62.2% after releasing topline results from a Phase 3 trial.

Portfolio Pulse from Lisa Levin

June 29, 2023 | 5:52 pm

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.